Population-level effects of suppressing fever

Proceedings of the Royal Society B: Biological Sciences

Volumn 281, Issue 1778, 2014, Pages

  Earn, David J D ^a,b   Andrews, Paul W ^a   Bolker, Benjamin M ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Antipyretic drugs; Fever; Influenza; Transmission

Indexed keywords

ADVERSE DRUG REACTION; ANTIPYRETIC AGENT; DRUG THERAPY;

DISEASE CONTROL; DISEASE TRANSMISSION; DISEASE TREATMENT; DRUG; INFECTIOUS DISEASE; INFLUENZA; POPULATION STRUCTURE;

ARTICLE; DISEASE TRANSMISSION; DRUG EFFECT; DRUG THERAPY; EPIDEMIC; EPIDEMIOLOGY; FEVER; HUMAN; INFLUENZA; TRANSMISSION; VIRUS SHEDDING;

ANTIPYRETIC DRUGS; FEVER; INFLUENZA; TRANSMISSION;

ADVERSE EFFECTS; ANTIPYRETICS; DRUG EFFECTS; DRUG THERAPY; EPIDEMICS; EPIDEMIOLOGY; FEVER; HUMANS; INFLUENZA, HUMAN; THERAPEUTIC USE; TRANSMISSION; VIRUS SHEDDING;

UNITED STATES;

EID: 84897506250     PISSN: 09628452     EISSN: 14712954     Source Type: Journal    
DOI: 10.1098/rspb.2013.2570     Document Type: Article

References (50)

1. Jack DB. 1997 One hundred years of aspirin. Lancet 350, 437-439. (doi:10.1016/S0140-6736(97)07087-6)
2. Mackowiak PA. 2000 Brief history of antipyretic therapy. Clin. Infect. Dis. 31, S154-S156. (doi:10.1086/317510)
3. Walsh A, Edwards H, Fraser J. 2007 Over-thecounter medication use for childhood fever: a crosssectional study of Australian parents. J. Paediatr. Child Health 43, 601-606. (doi:10.1111/j.1440-1754.2007.01161.x)
4. Ipp M, Jaffe D. 1993 Physicians' attitudes toward the diagnosis and management of fever in children 3 months to 2 years of age. Clin. Pediatr. 32, 66-70. (doi:10.1177/ 000992289303200201)
5. Thomas V, Riegel B, Andrea J, Murray P, Gerhart A, Gocka I. 1994 National survey of pediatric fever management practices among emergency department nurses. J. Emerg. Nurs. 20, 505-510.
6. Plaisance KI, Mackowiak PA. 2000 Antipyretic therapy. Arch. Intern. Med. 160, 449-456. (doi:10.1001/archinte.160.4.449)
7. Wood DM et al. 2010 Patient knowledge of the paracetamol content of over-the-counter (OTC) analgesics, cough/cold remedies and prescription medications. Emerg. Med. J. 27, 829-833. (doi:10.1136/emj.2009.085027)
8. Mackowiak PA. 2000 Physiological rationale for suppression of fever. Clin. Infect. Dis. 31, S185-S189. (doi:10.1086/ 317511)
9. Eyers S, Weatherall M, Shirtcliffe P, Perrin K, Beasley R. 2010 The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analyis. J. R. Soc. Med. 103, 403-411. (doi:10.1258/jrsm.2010.090441)
10. Kluger MJ. 1991 The adaptive value of fever. In Fever: basic mechanisms and management (ed. PA Mackowiak), pp. 105-124. New York, NY: Raven Press Ltd.
11. Hasday JD, Fairchild KD, Shanholtz C. 2000 The role of fever in the infected host. Microbes Infect. 2, 1891-1904. (doi:10.1016/S1286-4579(00)01337-X)
12. Blatteis CM. 2003 Fever: pathological or physiological, injurious or beneficial? J. Thermal Biol. 28, 1-13. (doi:10.1016/S0306-4565(02)00034-7)
13. Simon HB. 2003 Hyperthermia, fever, and fever of undetermined origin. In Infectious diseases: the clinician's guide to diagnosis, treatment, and prevention. (ed. DC Dale). New York, NY: WebMD Professional Publishing.
14. Murphy KM. 2011 Janeway's immunobiology, 8th edn. New York, NY: Garland Science.
15. Dinarello CA, Porat R. 2008 In Harrison's principles of internal medicine (eds AS Fauci, DL Kasper, DL LongoE Braunwald, SL Hauser, JL Jameson, J Loscalzo), 17th edn, p. 2958. New York, NY: McGraw-Hill.
16. Husseini RH, Sweet C, Collie MH, Smith H. 1982 Elevation of nasal viral levels by suppression of fever in ferrets infected with influenza viruses of differing virulence. J. Infect. Dis. 145, 520-524. (doi:10. 1093/infdis/145.4.520)
17. Kermack WO, McKendrick AG. 1927 A contribution to the mathematical theory of epidemics. Proc. R. Soc. Lond. A 115, 700-721. (doi:10.1098/ rspa.1927.0118)
18. Ma J, Earn DJD. 2006 Generality of the final size formula for an epidemic of a newly invading infectious disease. Bull. Math. Biol. 68, 679-702. (doi:10.1007/s11538-005-9047-7)
19. Anderson RM, May RM. 1991 Infectious diseases of humans: dynamics and control. Oxford, UK: Oxford University Press.
20. Earn DJD, Dushoff J, Levin SA. 2002 Ecology and evolution of the flu. Trends Ecol. Evol. 17, 334-340. (doi:10.1016/S0169-5347(02)02502-8)
21. Chowell G, Miller MA, Viboud C. 2008 Seasonal influenza in the United States, France, and Australia: transmission and prospects for control. Epidemiol. Infect. 136, 852-864. (doi:10.1017/ S0950268807009144)
22. Chowell G, Viboud C, Simonsen L, Miller M, Alonso WJ. 2010 The reproduction number of seasonal influenza epidemics in Brazil, 1996-2006. Proc. R. Soc. B 277, 1857-1866. (doi:10.1098/rspb.2009.1897)
23. Tuite AR et al. 2010 Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. Can. Med. Assoc. J. 182, 131-136. (doi:10.1503/cmaj.091807)
24. Katriel G, Yaari R, Huppert A, Roll U, Stone L. 2011 Modelling the initial phase of an epidemic using incidence and infection network data: 2009 H1N1 pandemic in Israel as a case study. J. R. Soc. Interface 8, 856-867. (doi:10.1098/rsif.2010.0515)
25. He D, Dushoff J, Day T, Ma J, Earn DJD. 2011 Mechanistic modelling of the three waves of the 1918 influenza pandemic. Theor. Ecol. 4, 283-288. (doi:10.1007/s12080-011-0123-3)
26. Earn DJD et al. 2012 Effects of school closure on incidence of pandemic influenza in Alberta, Canada. Ann. Intern. Med. 156, 173-181. (doi:10.7326/ 0003-4819-156-3-201202070-00005)
27. Ludwig D. 1975 Final size distribution for epidemics. Math. Biosci. 23, 33-46. (doi:10.1016/ 0025-5564(75)90119-4)
28. Drake JM. 2006 Limits to forecasting precision for outbreaks of directly transmitted diseases. PLoS Med. 3, 57-62. (doi:10.1371/journal.pmed. 0030003)
29. Brauer F. 2008 Age-of-infection and the final size relation. Math. Biosci. Eng. 5, 681-690.
30. Katriel G. 2012 The size of epidemics in populations with heterogeneous susceptibility. J. Math. Biol. 65, 237-262. (doi:10.1007/s00285-011-0460-2)
31. Miller JC, Slim AC, Volz EM. 2012 Edge-based compartmental modelling for infectious disease spread. J. R. Soc. Interface 9, 890-906. (doi:10. 1098/rsif.2011.0403)
32. R Development Core Team. 2012. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
33. Carrat F et al. 2008 Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am. J. Epidemiol. 167, 775-785. (doi:10.1093/aje/kwm375)
34. Matsuoka Y, Lamirande EW, Subbarao K. 2009 The ferret model for influenza. In Current protocols in microbiology, vol. 13, pp. 2.1-2.29. Hoboken, NJ: John Wiley & Sons.
35. Toms GL, Davies JA, Woodward CG, Sweet C, Smith H. 1977 The relation of pyrexia and nasal inflammatory response to virus levels in nasal washings of ferrets infected with influenza viruses of differing virulence. Br. J. Exp. Pathol. 58, 444-458.
36. Stanley ED, Jackson GG, Panusarn C, Rubenis M, Dirda V. 1975 Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA 231, 1248-1251. (doi:10.1001/jama.1975.0324024 0018017)
37. Doran TF, Deangelis C, Baumgardner RA, Mellits ED. 1989 Acetaminophen: more harm than good for chickenpox? J. Pediatr. 114, 1045-1048. (doi:10. 1016/S0022-3476(89)80461-5)
38. Plaisance KI, Kudaravalli S, Wasserman SS, Levine MM, Mackowiak PA. 2000 Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections. Pharmacotherapy 20, 1417-1422. (doi:10.1592/phco.20.19.1417.34865)
39. Yezli S, Otter JA. 2011 Minimum infective dose of the major human respiratory and enteric viruses transmitted through food and the environment. Food Environ. Virol. 3, 1-30.
40. Bolker BM et al. 2009 Generalized linear mixed models: a practical guide for ecology and evolution. Trends Ecol. Evol. 24, 127-135. (doi:10.1016/j.tree.2008.10.008)
41. Bates D, Maechler M, Bolker B. 2012 lme4: linear mixed-effects models using S4 classes. R package v. 0.999375-42. See http://CRAN.R-project.org/ package=lme4.
42. Yang Y et al. 2009 Transmissibility and control of pandemic influenza A (H1N1) virus. Science 326, 729-733. (doi:10.1126/science.1177373)
43. Dushoff J, Plotkin JB, Viboud C, Earn DJD, Simonsen L. 2006 Mortality due to influenza in the United States: an annualized regression approach using multiple-cause mortality data. Am. J. Epidemiol. 163, 181-187. (doi:10.1093/ aje/kwj024)
44. World Health Organization. 2009 Media centre: fact sheet 211. See http://www.who.int/mediacentre/ factsheets/fs211/en/.
45. Starko KM. 2009 Salicylates and pandemic influenza mortality, 1918-1919 pharmacology, pathology, and historic evidence. Clin. Infect. Dis. 49, 1405. (doi:10.1086/606060)
46. Schulman CI et al. 2005 The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg. Infect. 6, 369-375. (doi:10.1089/sur.2005.6.369)
47. Taubenberger JK, Morens DM. 2006 1918 influenza, the mother of all pandemics. Emerg. Infect. Dis. 12, 15-22. (doi:10.3201/eid1209.05-0979)
48. Patrozou E, Mermel LA. 2009 Does influenza transmission occur from asymptomatic infection or prior to symptom onset? Public Health Rep. 124, 193-196.
49. Loeb M et al. 2010 Effect of influenza vaccination of children on infection rates in Hutterite communities. JAMA 303, 943-950. (doi:10.1001/jama.2010.250)
50. DiazGranados CA, McGowan Jr JE. 2009 Antimicrobial resistance: an international public health problem. In Antimicrobial drug resistance (ed. DL Mayers), vol. 2, pp. 1267-1276. New York, NY: Springer Science+Business Media.